|
|
![]() Cancer ResearchScience & Technology St. Louis Bioscience in the Spotlight as BioGenerator Portfolio Tops $2 Billion in Follow-On Capital BioGenerator Ventures portfolio has raised $2.2 billion in follow-on capital, with much of the success involving one company in 2021. |
|
|
|
|
|
|
|